Efforts to create largest database on Siddha treatment focusing on COVID-19 begins


PTI, Jul 1, 2020, 10:47 AM IST

Chennai: Two premier Siddha institutes are involved in creating the largest-ever database on the use of the traditional medicine’s practices and measures among the population, and impact on the prevention of COVID-19 both in India and abroad, through the Ayush Sanjivani mobile app.

The Central Council for Research in Siddha (CCRS) and the National Institute of Siddha (NIS), have taken up the job and this repository will not only aid future research but also re-establish the validity of the Siddha system of medicine.

The study, through the app, is a part of the research being carried out by a Central task force, which includes researchers from the Ministry of Ayush, Ministry of Health and Family Welfare and the Indian Council of Medical Research (ICMR).

“The aim is to enlist the support of one billion users for the Ayush Sanjivani mobile app. Efforts to involve Siddha practitioners, research scholars, students, patients and their relatives are on,” Dr K Kanakavalli, Director General, CCRS, Chennai, said.

The app, which would record the experiences of the practitioners and patients, would create an evidence-based study on Siddha as prophylactic, intervention and immunity booster, she said. It would also record the experiences of the quarantined people who were treated with Siddha system of medicines.

In the case of the general public, the government will undertake a survey to ascertain if they have followed the advisory issued in March by the Ayush ministry on using home remedies to boost immunity against coronavirus.

According to Dr R S Ramaswamy, former Director-General, CCRS and Director, RVS Siddha Medical College, Coimbatore, certain yoga asanas and pranayama help to enhance one’s immunity levels.

“These too should be documented through the app,” he said.

“The Ayush ministry’s Ayush Sanjivani Mobile App is a good initiative. In the past, Siddha doctors demonstrated the efficacy of the medicines in treating dengue and chikungunya cases.

The Coronavirus crisis is an occasion for the doctors to prove that our system of medicine can successfully treat COVID-19 patients,” said Dr R Meenakumari Director, NIS, Chennai.

Even families, which had benefited could also download the app and share their experiences, she added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

‘We know every vote counts and take our responsibility very seriously’

Gukesh credits Vishwanathan Anand for his Chess journey

Judge handling Gyanvapi survey alleges receiving international calls

Political Battle Heats Up in Kerala and Maharashtra Ahead of Second Phase Polls

Congress leader Kharge pens letter to PM Modi, requests meeting to discuss ‘Nyay Patra’

Congress determined to weaken OBC quota by giving religion-based reservation: PM Modi

Watch: Remotely piloted IAF aircraft crashes in Jaisalmer

Related Articles More

Delhi HC adjourns hearing on Facebook, WhatsApp pleas challenging IT rules on traceability to August

Congress, SP harbor negative sentiments, alleges Yogi Adityanath

Judge handling Gyanvapi survey alleges receiving international calls

Political Battle Heats Up in Kerala and Maharashtra Ahead of Second Phase Polls

Congress leader Kharge pens letter to PM Modi, requests meeting to discuss ‘Nyay Patra’

MUST WATCH

Skin Rash, Causes, Signs and Symptoms

11 bullets found in python’s body!

K. Jayaprakash Hegde Sharing His Memories

Grafting Jack Anil

Heat Illness


Latest Additions

Delhi HC adjourns hearing on Facebook, WhatsApp pleas challenging IT rules on traceability to August

Congress, SP harbor negative sentiments, alleges Yogi Adityanath

‘We know every vote counts and take our responsibility very seriously’

Gukesh credits Vishwanathan Anand for his Chess journey

Judge handling Gyanvapi survey alleges receiving international calls

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.